Display Settings:

Format

Send to:

Choose Destination
    Allergy Proc. 1991 May-Jun;12(3):139-42.

    Leukotrienes.

    Source

    Department of Allergy and Allied Respiratory Disorders, Guy's Hospital, London, UK.

    Abstract

    Bronchial asthma is characterized by airways' inflammation and airways' hyperresponsiveness. It is unlikely that the pathophysiology of asthma and bronchial hyperresponsiveness can be explained on the basis of a single cell or a single class of mediators. Nevertheless, the possibility that leukotrienes may contribute to the pathogenesis of the inflammatory, vasoactive, and spasmogenic components of bronchial asthma is suggested by the properties of these lipid mediators, the preferential capacity of inflammatory cells to generate leukotrienes, and the presence of leukotrienes in the airways of asthmatic subjects.

    PMID:
    1654285
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Ingenta plc

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk